EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mortality of myasthenia gravis: a national population‐based study in China

Chen Zhang, Fei Wang, Zheng Long, Jia Yang, Yi Ren, Qingfeng Ma iD, Jiajian Li, Xinmei Wen, Lijun Wang, Yuwei Da iD, Maigeng Zhou, Peng Yin und 1 weitere

Annals of Clinical and Translational Neurology · 2023-07 · 10 (7) · 1095-1105

DOI: 10.1002/acn3.51792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 22.05.2023. Verfasst von Chen Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing, 100053, China. Hauptthemen laut MEDLINE: Myasthenia Gravis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

As a potentially life‐threatening condition, myasthenia gravis (MG) has limited epidemiological studies on mortality. We aim to provide demographic distribution, geographical variation, and temporal trend of MG‐related mortality in China.

Methods

The national population‐based analysis was conducted based on records derived from the National Mortality Surveillance System of China. All deaths related to MG were identified from 2013 to 2020, and MG‐related mortality was evaluated by sex, age, location, and year.

Results

A total of 4224 deaths were related to MG during 2013–2020, and the median age at death of MG was 59.45 years, significantly lower than that in the general population (75.47 years, P < 0.05). In 2020, the age‐standardized mortality rate of MG was 1.86 per million people and markedly higher in males than in females (2.37 vs. 1.31 per million). The mortality rate per million was lower than 1 in young children, peaking at 2.83 only in males (vs. 0.36 in females) aged 10–19 years, and substantially increased with age, reaching the highest rate of 13.31 for males and 10.58 for females aged 80 years and older. Geographical disparity across China was observed with the highest age‐standardized mortality rate in Southwest (2.53 per million). From 2013 to 2020, MG‐related mortality rate showed an increasing trend with the average annual percentage change of 3.5% (95% CI, 1.4–5.6). The notable increases occurred in age 10–19 years and over 70 years.

Interpretation

In China, MG‐related mortality was notably high among adolescent males and the elderly. The increasing death burden due to MG highlight challenges to disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisChildAgedMaleFemaleAdolescentHumansChild, PreschoolMiddle AgedAged, 80 and overChinaDisease Management

Autor:innen und Institutionen

  • Department of Neurology, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing, 100053, China.
  • National Center for Neurological Disorders, No. 45 Changchun Street, Xicheng District, Beijing, 100053, China.
  • Department of Neurology, PLA Rocket Force Characteristic Medical Center, No. 16 Xinjiekouwai Street, Xicheng District, Beijing, 100088, China.
  • National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 27 Nanwei Road, Xicheng District, Beijing, 100050, China.
  • Beijing Municipal Geriatric Medical Research Center, No. 45 Changchun Street, Xicheng District, Beijing, 100053, China.

ORCID-Profile: Qingfeng Ma, Yuwei Da, Junwei Hao

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Zhang, C., Wang, F., Long, Z., Yang, J., Ren, Y., Ma, Q., Li, J., Wen, X., Wang, L., Da, Y., Zhou, M., Yin, P., & Hao, J. (2023). Mortality of myasthenia gravis: a national population‐based study in China. Annals of Clinical and Translational Neurology, 10(7), 1095-1105. https://doi.org/10.1002/acn3.51792

Vancouver

Zhang C, Wang F, Long Z, Yang J, Ren Y, Ma Q, et al. Mortality of myasthenia gravis: a national population‐based study in China. Annals of Clinical and Translational Neurology. 2023;10(7):1095-1105. doi:10.1002/acn3.51792

BibTeX
@article{Zhang2023,
  author = {Zhang, Chen and Wang, Fei and Long, Zheng and Yang, Jia and Ren, Yi and Ma, Qingfeng and Li, Jiajian and Wen, Xinmei and Wang, Lijun and Da, Yuwei and Zhou, Maigeng and Yin, Peng and Hao, Junwei},
  title = {Mortality of myasthenia gravis: a national population‐based study in China},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2023},
  volume = {10},
  number = {7},
  pages = {1095--1105},
  doi = {10.1002/acn3.51792}
}
Kostenlos starten →